Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
South Korea
100%
Confidence Interval
83%
Intensive Care Unit
67%
Adult Patients
62%
Methicillin-resistant Staphylococcus Aureus
56%
Odds Ratio
47%
Risk Factors
46%
Clinical Outcomes
33%
Klebsiella Pneumoniae (K. pneumoniae)
31%
Vancomycin-resistant Enterococci
31%
Candidemia
31%
Septic Shock
31%
AIDS/HIV
31%
Community-acquired
30%
Bacteremia
29%
Clinical Significance
29%
Epidemiological Characteristics
28%
Severe Sepsis
27%
Healthcare Workers
27%
University Hospital
27%
Antibiotics
27%
Carbapenem-resistant Acinetobacter Baumannii
26%
COVID-19
25%
Vancomycin
24%
Community-acquired Pneumonia
24%
Teaching Hospital
24%
Staphylococcus Aureus Bacteremia
23%
Infective Endocarditis
23%
Liver Abscess
23%
Prospective Observational Study
23%
In-hospital Mortality
23%
Epidemiology
22%
Tuberculosis
22%
Sepsis
21%
Legionella
21%
Fever
20%
Molecular Analysis
19%
Legionella Pneumophila
18%
Hepatitis A
18%
Extended-spectrum-lactamase
18%
Immunogenicity
17%
Epidemiologic Studies
17%
Clinical Characteristics
17%
Hazard Ratio
17%
Sepsis Shock
17%
Disease Severity
17%
Influenza
17%
Immunocompromised Patients
16%
Healthcare-associated
16%
Antibiotic Use
16%
Pharmacology, Toxicology and Pharmaceutical Science
Diseases
65%
Coronavirinae
63%
Carbapenem
49%
Acinetobacter Baumannii
45%
Observational Study
41%
Infection
36%
Bloodstream Infection
34%
Antibiotics
34%
Immunogenicity
33%
Disease
33%
Live Attenuated Influenza Vaccine
32%
Candidemia
31%
Adverse Event
31%
Escherichia coli
30%
Case-Control Study
29%
Cohort Study
27%
Methicillin Resistant Staphylococcus Aureus Infection
24%
HIV
24%
SARS Coronavirus
24%
Antiinfective Agent
24%
Prevalence
23%
mRNA Vaccine
23%
Septic Shock
23%
Sepsis
23%
Epidemiology
21%
Vancomycin
21%
Penicillinase
20%
Hospital Mortality
20%
Normal Human
19%
Flu Like Syndrome
17%
Comorbidity
16%
Community Acquired Pneumonia
15%
Influenza A (H1N1)
15%
Vancomycin-Resistant Enterococcus
15%
Pneumococcal Infection
15%
Influenza A
15%
AS03
15%
Recombinant Protein
15%
Nanoparticle
15%
Infectious Agent
15%
Combination Therapy
13%
Retrospective Study
13%
Hospital Infection
12%
Linezolid
12%
Antibiotic Therapy
12%
Influenza A Virus (H1N1)
11%
Messenger RNA
11%
Multidrug Resistance
11%
Mortality Rate
11%
Methicillin-Resistant Staphylococcus Aureus
11%
Medicine and Dentistry
COVID-19
83%
Infection
45%
Pathogen
39%
Disease
32%
Sepsis
32%
Clinical Significance
31%
Cohort Effect
28%
Prevalence
27%
Serotype
27%
Odds Ratio
26%
Intensive Care Unit
24%
Antibiotics
24%
Candidemia
23%
Infective Endocarditis
23%
Liver Abscess
23%
Carbapenem
23%
Adverse Event
22%
Empyema
21%
Septic Shock
21%
Observational Study
21%
Bloodstream Infection
21%
Health Care
21%
Hazard Ratio
19%
Cohort Analysis
19%
Influenza Vaccine
18%
Case-Control Study
17%
Streptococcus Pneumonia
15%
Community-Acquired Pneumonia
15%
Mycobacterium Avium-Intracellulare Infection
15%
mRNA Vaccine
15%
Severe Acute Respiratory Syndrome Coronavirus 2
15%
Immunogenicity
15%
Acinetobacter Baumannii
15%
Human Immunodeficiency Virus
15%
Influenza A
14%
Infection Control
13%
Group Therapy
13%
Antiinfective Agent
13%
Immunocompromised Patient
12%
Multivariate Logistic Regression Analysis
12%
Subgroup Analysis
12%
Hospital Mortality
12%
Prognostic Factor
12%
Sputum
11%
Electronic Patient Record
11%
Diseases
11%
Antibiotic Therapy
11%
Escherichia coli
11%
Messenger RNA
10%
Retrospective Study
10%